株式会社ステムリム
Osaka, Japan
Active| Registration number | T6120901018131 |
|---|---|
| Type | Corporation |
| Registered name | 株式会社ステムリム |
| Address | 大阪府茨木市彩都あさぎ７丁目７番１５号 7-7-15 Saitoasagi, Ibaraki-shi, Osaka 567-0085, JAPAN |
| Corporate number | 6120901018131 |
| Corporate number assigned on | 2015-10-05 |
| Invoice registered on | 2023-10-01 |
The invoice registration date is when the qualified-invoice-issuer registration (T-number) took effect — it is not the date the company was founded, and it resets only if the business re-registers after revocation or expiry.
Corporate registry record
| Entity type | Kabushiki Kaisha (stock company) |
|---|---|
| Representative | 代表取締役社長CEO 岡島 正恒 |
| Reading (furigana) | ステムリム |
| Reading (romaji) | Sutemurimu |
| English name (unofficial) | Sutemurimu K.K. |
| Postal code | 567-0085 |
Source: NTA Corporate Number Publication Site, refreshed daily. Representative: gBizINFO (METI, monthly).
Company profile (gBizINFO)
| Business summary | 再生誘導医薬の研究開発 |
|---|---|
| Business lines | L:学術研究、専門・技術サービス業 |
| Employees | 45 （male 19 / female 26） |
| Capital | ¥10.0M |
| Website | stemrim.com/ |
Source: gBizINFO (METI), refreshed monthly — edited extract by LoreaTec. Figures are as filed by each company.
Government contract awards (GEPS)
No public national-government (GEPS) award records for this company in the open data (FY2013 to date).
出典：調達ポータル（https://www.p-portal.go.jp/）
Subsidies & grants received (gBizINFO)
2 published awards (2019-04-01 → 2019-04-01, 1 programme, total ¥44.8M).
| 2019-04-01 | 平成３１年度中小企業経営支援等対策費補助金（戦略的基盤技術高度化支援事業）「網羅的遺伝子解析技術を利用した細胞治療用間葉系幹細胞集積・採取技術および再生誘導医薬評価系の開発」【株式会社ステムリム】 ¥22.4M （経済産業省） |
|---|---|
| 2019-04-01 | 平成３１年度中小企業経営支援等対策費補助金（戦略的基盤技術高度化支援事業）「網羅的遺伝子解析技術を利用した細胞治療用間葉系幹細胞集積・採取技術および再生誘導医薬評価系の開発」【株式会社ステムリム】 ¥22.4M （経済産業省） |
Source: gBizINFO (METI) subsidy information, refreshed monthly. Amounts as published (grant decisions). Subsidies database →
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2025–2025; total ¥12.1M).
| 2025 FY2024 | 医療・健康推進事業（うち再生医療・遺伝子治療の産業化に向けた基盤技術開発事業） ¥12.1M （経済産業省） 民間企業を中心とした実用化において、プロジェクトの実施を担う機関 |
|---|
Contract details (excerpt): 再生・細胞医療・遺伝子治療産業化促進事業（重症栄養障害型表皮水疱症に対する根治的遺伝子治療技術開発） ¥12.1M・補助金等交付 · bidders 22
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Verify in official sources
Doing due diligence on this supplier?
Verifying the invoice number is step one. Our guide covers the full checklist: corporate registry, licenses, and import/export standing.
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t6120901018131) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-21.
Reusing this page, or answering with it? Paste this line. Training and AI answers are allowed — attribution is the only condition. AI content licence